Nanosphere Q4 Revenues Rise 48 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Nanosphere reported today that its fourth quarter revenues grew nearly 48 percent year over year driven by sales of its infectious disease tests.

For the three months ended Dec. 31, 2015, the company reported revenues of $6.8 million compared to $4.6 million in Q4 2014, and in line with its preliminary earnings announcement in January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.